Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Beta-blockers in the Elderly PDF full book. Access full book title Beta-blockers in the Elderly by Bengt Åblad. Download full books in PDF and EPUB format.
Author: Bengt Åblad Publisher: Springer ISBN: Category : Medical Languages : en Pages : 126
Book Description
In conjunction with the Twelfth International Congress of Gerontology, the Carl-Korth Institute for Cardiovascular Research organized an international symposium on "Beta Blockers in the Elderly." It was the intention of the Scientific Committee that during this symposium we would discuss the specific problems and therapeutic implications arising when elderly people have to be treated with beta-blocking agents. Special emphasis was placed on the side effects and the age dependent features of beta-blocker therapy. Beta-blockers have become established in the treatment of both cardiovascular diseases and neuropsychiatric disorders. Their effectiveness in patients suffering from coronary heart disease, hypertension, and hyperkinetic cardiac syndromes has long been proven. The development of new, selectively active beta-blockers has substantially reduced the number of possible side effects, thus enhancing therapeutic safety. Because side effects cannot be eliminated, however, beta blockers have been introduced only hesitantly into treatment of the elderly. This book is the first wide-ranging survey of the use of beta blockers in elderly patients. The articles contained herei- written by pharmacologists, cardiologists, sports physicians, neurologists, psychiatrists, and ophthalmologists - show that advanced age alone does not contraindicate the use of beta-blockers and sympatholytic substances. Also provided are guidelines for examination and determination of in dications in the elderly. Both the symposium and the publication of this volume have been kindly supported by Astra Chemicals, West Germany.
Author: Bengt Åblad Publisher: Springer ISBN: Category : Medical Languages : en Pages : 126
Book Description
In conjunction with the Twelfth International Congress of Gerontology, the Carl-Korth Institute for Cardiovascular Research organized an international symposium on "Beta Blockers in the Elderly." It was the intention of the Scientific Committee that during this symposium we would discuss the specific problems and therapeutic implications arising when elderly people have to be treated with beta-blocking agents. Special emphasis was placed on the side effects and the age dependent features of beta-blocker therapy. Beta-blockers have become established in the treatment of both cardiovascular diseases and neuropsychiatric disorders. Their effectiveness in patients suffering from coronary heart disease, hypertension, and hyperkinetic cardiac syndromes has long been proven. The development of new, selectively active beta-blockers has substantially reduced the number of possible side effects, thus enhancing therapeutic safety. Because side effects cannot be eliminated, however, beta blockers have been introduced only hesitantly into treatment of the elderly. This book is the first wide-ranging survey of the use of beta blockers in elderly patients. The articles contained herei- written by pharmacologists, cardiologists, sports physicians, neurologists, psychiatrists, and ophthalmologists - show that advanced age alone does not contraindicate the use of beta-blockers and sympatholytic substances. Also provided are guidelines for examination and determination of in dications in the elderly. Both the symposium and the publication of this volume have been kindly supported by Astra Chemicals, West Germany.
Author: E. Lang Publisher: Springer ISBN: 9783642686757 Category : Medical Languages : en Pages : 107
Book Description
In conjunction with the Twelfth International Congress of Gerontology, the Carl-Korth Institute for Cardiovascular Research organized an international symposium on "Beta Blockers in the Elderly." It was the intention of the Scientific Committee that during this symposium we would discuss the specific problems and therapeutic implications arising when elderly people have to be treated with beta-blocking agents. Special emphasis was placed on the side effects and the age dependent features of beta-blocker therapy. Beta-blockers have become established in the treatment of both cardiovascular diseases and neuropsychiatric disorders. Their effectiveness in patients suffering from coronary heart disease, hypertension, and hyperkinetic cardiac syndromes has long been proven. The development of new, selectively active beta-blockers has substantially reduced the number of possible side effects, thus enhancing therapeutic safety. Because side effects cannot be eliminated, however, beta blockers have been introduced only hesitantly into treatment of the elderly. This book is the first wide-ranging survey of the use of beta blockers in elderly patients. The articles contained herei- written by pharmacologists, cardiologists, sports physicians, neurologists, psychiatrists, and ophthalmologists - show that advanced age alone does not contraindicate the use of beta-blockers and sympatholytic substances. Also provided are guidelines for examination and determination of in dications in the elderly. Both the symposium and the publication of this volume have been kindly supported by Astra Chemicals, West Germany.
Author: E. Lang Publisher: Springer Science & Business Media ISBN: 3642686745 Category : Medical Languages : en Pages : 133
Book Description
In conjunction with the Twelfth International Congress of Gerontology, the Carl-Korth Institute for Cardiovascular Research organized an international symposium on "Beta Blockers in the Elderly." It was the intention of the Scientific Committee that during this symposium we would discuss the specific problems and therapeutic implications arising when elderly people have to be treated with beta-blocking agents. Special emphasis was placed on the side effects and the age dependent features of beta-blocker therapy. Beta-blockers have become established in the treatment of both cardiovascular diseases and neuropsychiatric disorders. Their effectiveness in patients suffering from coronary heart disease, hypertension, and hyperkinetic cardiac syndromes has long been proven. The development of new, selectively active beta-blockers has substantially reduced the number of possible side effects, thus enhancing therapeutic safety. Because side effects cannot be eliminated, however, beta blockers have been introduced only hesitantly into treatment of the elderly. This book is the first wide-ranging survey of the use of beta blockers in elderly patients. The articles contained herei- written by pharmacologists, cardiologists, sports physicians, neurologists, psychiatrists, and ophthalmologists - show that advanced age alone does not contraindicate the use of beta-blockers and sympatholytic substances. Also provided are guidelines for examination and determination of in dications in the elderly. Both the symposium and the publication of this volume have been kindly supported by Astra Chemicals, West Germany.
Author: Stephen Jackson Publisher: John Wiley & Sons ISBN: 9780470024294 Category : Medical Languages : en Pages : 552
Book Description
A guide for doctors to quickly choose the right drugs in the right dose for the most important clinical problems in the elderly Prescribing medications for elderly patients is complex - this book gives clear advice on treatment regimes, drug interactions, adverse effects, and recommended dose changes Provides practical help with the problems that can arise in reaching an accurate diagnosis in the elderly, recommends clear treatment options, lists key drug interactions and side effects, and advises when to amend doses
Author: Ronda Hughes Publisher: Department of Health and Human Services ISBN: Category : Medical Languages : en Pages : 592
Book Description
"Nurses play a vital role in improving the safety and quality of patient car -- not only in the hospital or ambulatory treatment facility, but also of community-based care and the care performed by family members. Nurses need know what proven techniques and interventions they can use to enhance patient outcomes. To address this need, the Agency for Healthcare Research and Quality (AHRQ), with additional funding from the Robert Wood Johnson Foundation, has prepared this comprehensive, 1,400-page, handbook for nurses on patient safety and quality -- Patient Safety and Quality: An Evidence-Based Handbook for Nurses. (AHRQ Publication No. 08-0043)." - online AHRQ blurb, http://www.ahrq.gov/qual/nurseshdbk/
Author: Adam Schneeweiss Publisher: Springer Science & Business Media ISBN: 1461320631 Category : Medical Languages : en Pages : 391
Book Description
Cardiovascular drug therapy has markedly progressed in the recent decades. Not only have new drugs been introduced to clinical practice, but new classes of drugs have been developed. While in 1960 the practicing cardiolo gist had a selection of about only ten drugs, in 1987 about 150 drugs are routinely used in cardiovascular diseases. Elderly patients, however, usually do not enjoy the full benefit of this progress. This might be due to lack of knowledge, a conservative approach, or the worldwide tendency not to try new drugs in the elderly. It is now clear that the majority of patients that will be treated in car diovascular clinics will be, in the near future, elderly patients. Even now, elderly patients form about one-third of the patients with cardiovascular diseases. These patients are approached, however, according to criteria devel oped for younger populations. This is despite the fact that elderly patients differ from younger ones in most aspects, including pathology, epidemiol ogy, pathophysiology, diagnostic approach, management, pharmacology, pharmacokinetics, rehabilitation, and supportive treatment. It is the purpose of this book to present to the clinician all drugs with which there is clinical experience in the elderly or which might be potentially useful for the elderly with cardiovascular diseases. The data are presented without the authors taking a position. This should allow the clinicians to make their own selection and individualize treatment, vii viii Preface based on a wide data base. Comparative data are presented only when specific comparative studies were performed.
Author: Bengt Åblad
Author: Bengt Åblad
Author: E. Lang
Author: 
Author: 
Author: E. Lang
Author: Stephen Jackson
Author: Richard W. Sloan
Author: Jeffrey C. Delafuente
Author: Ronda Hughes
Author: Adam Schneeweiss